View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Uncategorised
September 8, 2020

Coronavirus company news summary – BillionToOne secures EUA for SARS-CoV-2 diagnostic test – India’s Union Health Ministry updates Covid-19 testing strategy

By Chloe Kent

Diagnostics company BillionToOne has secured Emergency Use Authorisation (EUA) from the US Food and Drug Administration (FDA) for its SARS-CoV-2 diagnostic test, which is designed to remove the costly and time-consuming step of RNA extraction. Compared with most other molecular assays that depend on RNA extraction and qRT-PCR, the firm’s qSanger-COVID-19 assay makes use of a different set of instruments and chemicals from existing tests, which in turn allows labs to tap a new, unused capacity for the detection of Covid-19 causing SARS-CoV-2.

Swiss company ender diagnostics has announced collaboration with Swiss International Air Lines (SWISS), a subsidiary of Lufthansa, to test all long-haul cabin crew members for SARS-CoV-2. Testing the long-haul crew members of SWISS before departure will help to further boost detection of Covid-19 infection and boost the safety of people travelling.

The Union Health Ministry of India has updated its advisory on testing strategy for Covid-19. It has introduced on-demand testing without the need for a prescription. However, it has allowed the state health authorities to alter the modules according to their requirements.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network